Becton, Dickinson and Company's stock has shown significant movements over the past months. As a leader in the medical sector, the company's price actions reflect its strategic initiatives and market responses. Understanding the stock trends and crucial support and resistance levels will aid investors and stakeholders in making informed decisions.
Based on the analysis of daily closing prices for Becton, Dickinson and Company over the past months, there has been notable volatility. Calculating the EMA20 and EMA50 suggests the stock is currently in a ▼ downtrend as EMA20 is below EMA50. The following table presents the trend insights for the recent week:
| Date | Closing Price | Trend |
|---|---|---|
| 2025-10-31 | 178.71 | ▼ |
| 2025-10-30 | 179.38 | ▼ |
| 2025-10-29 | 181.52 | ▼ |
| 2025-10-28 | 184.21 | ▼ |
| 2025-10-27 | 187.04 | ▼ |
| 2025-10-24 | 185.83 | ▲ |
| 2025-10-23 | 186.53 | ▲ |
Technically, the current downtrend indicates caution for short-term investors, although a reversal could be possible if supported by future upward price movements.
Analyzing the closing prices, the following support and resistance zones are identified:
| Zone Type | From | To |
|---|---|---|
| ▲ Support 1 | 170.00 | 175.00 |
| ▲ Support 2 | 180.00 | 185.00 |
| ▼ Resistance 1 | 190.00 | 195.00 |
| ▼ Resistance 2 | 200.00 | 205.00 |
Currently, the stock is in the lower support zone, indicating potential buyer interest at these levels. A breach below could suggest further downside potential.
The current analysis suggests that Becton, Dickinson and Company is in a short-term downtrend, with potential buying opportunities within the identified support zones. As the stock hovers near critical support zones, investors should remain vigilant for any trend reversals which could indicate a shift. However, with identified resistance zones, the upside might be capped without considerable market sentiment improvement. Overall, while there are risks in the current market environment, there are also opportunities for cautious investors.